Psychiatry · Mental health

Depression treatment in China

Class A psychiatry departments at major academic centres offer evidence-based depression care — pharmacotherapy, psychotherapy (CBT, IPT), and structured follow-up — with English-speaking clinicians available.

← All conditions

Overview

Major depressive disorder is one of the most common psychiatric conditions globally — and one of the most treatable when addressed promptly. Effective treatments exist; outcomes are best when combination care (medication + therapy) is matched to severity. Class A academic psychiatry departments in China offer this care at substantially lower cost than US/UK/AU private pay.

Common symptoms

  • Depressed mood most of the day, nearly every day
  • Markedly diminished interest or pleasure (anhedonia)
  • Significant weight change or appetite disturbance
  • Insomnia or hypersomnia
  • Fatigue or loss of energy
  • Feelings of worthlessness or excessive guilt
  • Diminished concentration
  • Thoughts of death or self-harm — clinical attention warranted regardless of total severity

Risk factors

  • Family history
  • Prior depressive episodes
  • Chronic medical illness
  • Substance use
  • Stressful life events, relationship loss
  • Postpartum (separate clinical entity)

Standard diagnostic workup

Cost band at Class A international department: USD 140280 all-in.

  • Structured psychiatric interview
  • PHQ-9 severity score
  • Differential rule-out: thyroid (TSH), B12, vitamin D, sleep, substance use, medical mimics
  • Suicide risk assessment
  • Past treatment review and response history

Treatment options

First-line

SSRIs (sertraline, escitalopram)

First-line pharmacotherapy. Generic, inexpensive in China at USD 5–25/month.

First-line

SNRIs (venlafaxine, duloxetine)

Particularly useful when comorbid pain or anxiety predominate.

First-line

Cognitive behavioural therapy (CBT)

Strongest evidence for psychotherapy in depression. Available in English-speaking format at major academic centres.

First-line

Interpersonal therapy (IPT)

Equally effective with CBT for many patients, particularly when relationship / role transitions predominate.

First-line

Combination medication + therapy

Standard of care for moderate-to-severe depression; outperforms either alone.

Selected cases

Treatment-resistant approaches (esketamine, augmentation)

For patients failing 2+ adequate trials. Available at academic psychiatry departments.

Frequently asked

How severe is my depression?
Take our free PHQ-9 self-test for the global standard depression screener. Scores of 10+ warrant clinical evaluation.
Are mental health treatments confidential in China?
Yes within standard medical confidentiality protections. Class A psychiatry departments at academic hospitals (Shanghai Mental Health Center, PKU Sixth) treat international patients with the same protections as domestic.
What if I'm in crisis right now?
Contact local emergency services immediately. Self-harm or suicidal thoughts always warrant urgent in-person evaluation, not an online screener.
Self-assessment

Depression screener (PHQ-9)

The 9-item Patient Health Questionnaire — the most widely used validated depression screener in primary care worldwide. Free, 3 minutes, immediate results.

Take the Depression screener

Talk to a senior physician

Free 30-minute video consult to review your case. We'll quote a workup and treatment plan at a Class A partner hospital — no commitment.

Book free consult